Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Patent Reform Expected To Get Senate Attention Soon

This article was originally published in The Gray Sheet

Executive Summary

The full Senate will take up patent reform legislation as soon as late January or early February, Senate Judiciary staff told "The Gray Sheet.

You may also be interested in...



House-Cleared Patent Reform Bill Is Likely Not The Final Word

A sponsor of the House-passed patent reform bill indicated that a provision strongly opposed by device firms is likely to be revised before it becomes law

Patent Reform Bills Clear House And Senate Judiciary Committees

The House and Senate Judiciary Committees each approved versions of patent reform legislation last week that respond to some concerns raised by device and drug lobbyists, but industry will seek more changes before the bills go to a floor vote

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025679

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel